Advertisement

Down 14.5%, Is Pfizer Stock a Screaming Buy?

Down 14.5%, Is Pfizer Stock a Screaming Buy?

Pfizer's declining COVID-19 franchise and upcoming patent expirations have weighed heavily on its stock.